Suzhou Ribo Life Science Co. Ltd.
168 Yuanfeng Road
Yushan Town
Kunshan
Jiangsu
215300
China
Tel: 86-512-57017802
Fax: 86-512-57017805
Website: http://www.ribolia.com
Email: office@ribolia.com
About Suzhou Ribo Life Science Co. Ltd.
Suzhou Ribo Life Sciences Co. Ltd. (Ribo) was founded in 2007 and is located in Kunshan, China. Ribo is devoted to the development of nucleic acid drugs and other related products based on RNA interference (RNAi) technology. The company was founded by Dr. Zicai Liang to partner with the Kunshan Institute of siRNA in an effort to clinically advance RNAi therapeutics in China. With China's biggest team of scientists and staff focused solely on RNAi research and development, Ribo and its Kunshan RNAi Institute partnership represents one of the world's leading efforts to develop RNAi therapeutics.YEAR FOUNDED:
2007
LEADERSHIP:
Founder and CEO: Zicai Liang
JOBS:
Please click here for Ribo job opportunities.
CLINICAL TRIAL:
Please click here for clinical trial information.
5 articles about Suzhou Ribo Life Science Co. Ltd.
-
Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases
1/3/2024
Suzhou Ribo Life Science Co., Ltd. and Ribocure AB announced a collaboration with Boehringer Ingelheim to develop novel treatments for nonalcoholic or metabolic dysfunction-associated steatohepatitis.
-
In a collaboration agreement announced Wednesday, Boehringer Ingelheim will gain access to Ribo’s platform to target hepatocytes with investigational siRNA therapies for nonalcoholic or metabolic dysfunction-associated steatohepatitis.
-
Suzhou Ribo Life Science Co. Ltd. Forms Broad ssRNAi Collaboration With Ionis Pharma
4/20/2017
-
Ionis Pharma Enters Into Collaboration With Suzhou Ribo Life Science Co. Ltd. To Advance RNA-Targeted Therapeutics In China
4/18/2017
-
Suzhou Ribo Life Science Co. Ltd. Lands $39 Million B Round For siRNA Portfolio
3/21/2017